 |
FDA Approval Activities for this Drug
Midodrine Hydrochloride Tablets, Mylan ANDA 76-577 9/10/03
Midodrine Hydrochloride Tablets, Eon Labs, ANDA 76-514 ProAmatine (midodrine hydrochloride) Tablets, 2.5 mg and 5 mg Shire NDA 19-815/S-005 MIDODRINE HYDROCHLORIDE Tablet; 2.5MG MIDODRINE HCL Eon 076514 MIDODRINE HYDROCHLORIDE Tablet; 5MG MIDODRINE HCL Eon 076577 MIDODRINE HYDROCHLORIDE Tablet; 10MG MIDODRINE HCL Mylan
076577 MIDODRINE HYDROCHLORIDE Tablet; 2.5MG MIDODRINE HCL Mylan
076577 MIDODRINE HYDROCHLORIDE Tablet; 5MG MIDODRINE HCL Mylan
019815 MIDODRINE HYDROCHLORIDE Tablet; 10MG PROAMATINE SHIRE 019815 MIDODRINE HYDROCHLORIDE Tablet; 2.5MG PROAMATINE SHIRE 019815 MIDODRINE HYDROCHLORIDE Tablet; 5MG PROAMATINE SHIRE Midodrine Hydrochloride Tablets, Impax Laboratories Midodrine Hydrochloride Tablets, Eon Labs, Approval ProAmatine (midodrine hydrochloride) Tablets, Shire Laboratories, Labeling Revision | Orvaten (Midodrine Hydrochloride) Tablets, Upsher-Smith Labs, Approval
For the most up-to-date approval information, please locate this API using the drug index.
|